The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of initial adjustment dose of apalutamide with progression to castration-resistant prostate cancer and skin-adverse events in men with metastatic castration-sensitive prostate cancer: A multicenter retrospective study of CsJUC cohort.
 
Yoichiro Tohi
No Relationships to Disclose
 
Takuma Kato
No Relationships to Disclose
 
Keita Kobayashi
No Relationships to Disclose
 
Kei Daizumoto
No Relationships to Disclose
 
Hideo Fukuhara
No Relationships to Disclose
 
Shin Ohira
No Relationships to Disclose
 
Satoshi Katayama
No Relationships to Disclose
 
Ryutaro Shimizu
No Relationships to Disclose
 
Atsushi Takamoto
No Relationships to Disclose
 
Kenichi Nishimura
No Relationships to Disclose
 
Kenichiro Ikeda
No Relationships to Disclose
 
Taichi Nagami
No Relationships to Disclose
 
Mikio Sugimoto
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Janssen; Kissei Pharmaceutical; Nippon Shinyaku; Novartis; Pfizer; Takeda